abstract |
The present invention relates to methods, compounds, compositions and vehicles for the delivery of 3-amino-1-propanesulfonic acid (3APS) in a subject, preferably a human subject. The present invention includes compounds that produce or generate 3APS in vitro or in vivo. Preferred compounds include amino acid prodrugs of 3APS for use including but not limited to the prevention and treatment of Alzheimer's disease. |